These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17550984)

  • 1. Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer.
    Siegfried JM; Gubish CT; Rothstein ME; Queiroz de Oliveira PE; Stabile LP
    Mol Pharmacol; 2007 Sep; 72(3):769-79. PubMed ID: 17550984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
    Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
    Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
    Qiao H; Hung W; Tremblay E; Wojcik J; Gui J; Ho J; Klassen J; Campling B; Elliott B
    J Cell Biochem; 2002; 86(4):665-77. PubMed ID: 12210733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
    Takeuchi S; Wang W; Li Q; Yamada T; Kita K; Donev IS; Nakamura T; Matsumoto K; Shimizu E; Nishioka Y; Sone S; Nakagawa T; Uenaka T; Yano S
    Am J Pathol; 2012 Sep; 181(3):1034-43. PubMed ID: 22789825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.
    Zheng Y; Ritzenthaler JD; Sun X; Roman J; Han S
    Cancer Res; 2009 Feb; 69(3):896-904. PubMed ID: 19176380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
    Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
    J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-targeting c-Met and COX-2 leads to enhanced inhibition of lung tumorigenesis in a murine model with heightened airway HGF.
    Stabile LP; Rothstein ME; Gubish CT; Cunningham DE; Lee N; Siegfried JM
    J Thorac Oncol; 2014 Sep; 9(9):1285-93. PubMed ID: 25057941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancer.
    Yamada T; Takeuchi S; Kita K; Bando H; Nakamura T; Matsumoto K; Yano S
    J Thorac Oncol; 2012 Feb; 7(2):272-80. PubMed ID: 22089117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research progress of HGF/MET signaling pathway in EGFR-TKI resistance 
in non-small cell lung cancer].
    Song S; Bi M
    Zhongguo Fei Ai Za Zhi; 2014 Oct; 17(10):755-9. PubMed ID: 25342043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A; Götze T; Korc M
    Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer.
    Yamada T; Matsumoto K; Wang W; Li Q; Nishioka Y; Sekido Y; Sone S; Yano S
    Clin Cancer Res; 2010 Jan; 16(1):174-83. PubMed ID: 20008840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of hepatocyte growth factor signaling augmented oridonin-induced death in human non-small cell lung cancer A549 cells via c-met-nuclear factor-κB-cyclooxygenase-2 and c-Met-Bcl-2-caspase-3 pathways.
    Liu Y; Shi QF; Qi M; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2012; 35(7):1150-8. PubMed ID: 22791165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
    Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
    J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells.
    Nishimura Y; Hyuga S; Takiguchi S; Hyuga M; Itoh K; Hanawa T
    Int J Oncol; 2016 May; 48(5):1895-906. PubMed ID: 26983447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that depletion of the sorting nexin 1 by siRNA promotes HGF-induced MET endocytosis and MET phosphorylation in a gefitinib-resistant human lung cancer cell line.
    Nishimura Y; Takiguchi S; Ito S; Itoh K
    Int J Oncol; 2014 Feb; 44(2):412-26. PubMed ID: 24297483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.
    Dohadwala M; Yang SC; Luo J; Sharma S; Batra RK; Huang M; Lin Y; Goodglick L; Krysan K; Fishbein MC; Hong L; Lai C; Cameron RB; Gemmill RM; Drabkin HA; Dubinett SM
    Cancer Res; 2006 May; 66(10):5338-45. PubMed ID: 16707460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.
    Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H
    Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
    Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathway involved in cyclooxygenase-2 up-regulation by hepatocyte growth factor in endometrial cancer cells.
    Yoshizawa Y; Yamada Y; Kanayama S; Shigetomi H; Kawaguchi R; Yoshida S; Nagai A; Furukawa N; Oi H; Kobayashi H
    Oncol Rep; 2011 Oct; 26(4):957-64. PubMed ID: 21687953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.